AHR and lung cancer: In the case of CYP1A1, a study by Anttila et al. [17] showed the methylation level of its promoter to increase within 1–7 days after quitting smoking in lung cancer which may inhibit the binding of AhR/ARNT heterodimer and subsequently lead to a reduction of CYP1A1 expression.